A Critical Review of the New Medical Cannabis Regulatory Regime in California

Instructor: Erik Janus
Product ID: 704578
  • Duration: 60 Min
Purchase option for this webinar is currently unavailable. Please contact our Customer Care for more info.

Customer Care

Fax: +1-650-963-2556


Read Frequently Asked Questions

This training program will examine key questions on how California’s future medical cannabis market will look like when it comes to regulation. In the next two years, multiple state agencies will be involved in filling in the blank spaces left by MMRSA. For example: What will licensure fees look like? How will “edibles” be regulated in California? In the background, a new President will be elected soon and this could influence the future of all state-based medical cannabis markets. Insight and opinion on all these issues will be provided by a regulatory expert with years of expertise in influencing state and federal decision-making and policy.

Why Should You Attend:

On January 1, 2016, a trio of bills signed into law by California Governor Jerry Brown went into effect that overhaul the regulation of medical cannabis in the Golden State for the first time in 20 years, known as the Medical Marijuana Regulation and Safety Act (MMRSA). The new laws call for regulations to be crafted by 2018; however, there is already a slew of new regulations to become accustomed to in a state that has long become comfortable with its relatively unregulated condition.

This webinar will help attendees understand the pros and cons of MMRSA as well as the challenges and barriers that remain to full and effective implementation of a new, well-regulated medical cannabis market in the state of California.

Areas Covered in the Webinar:

  • The history and use of cannabis sativa as a medicine will be reviewed.
  • The history of cannabis prohibition and regulation in California and the US will be reviewed.
  • A detailed review and critique of Medical Marijuana Regulation and Safety Act (MMRSA) will be presented.
  • The challenges and obstacles that remain in the way of full and effective implementation will be discussed.
  • Insight into how the regulation will impact state and regional market conditions will be provided.
  • Tips and advice for interacting with state and federal governments to influence regulatory decision-making will be provided.

Who Will Benefit:

  • HR Managers
  • Safety Managers
  • Facility Managers
  • Attorneys
  • Risk Managers
  • Nurses
  • Physicians
  • Laboratory Personnel
  • Pharmacy Staff
  • Pharmaceuticals
  • Medical Devices and Equipment
  • Homeopaths
  • Naturopaths
  • Farmers
  • Engineers
  • Investors and Entrepreneurs
  • Local, Sate and Federal Law Regulators
  • Environmental Scientists
  • Environmental Health Specialists
  • Non-governmental organizations concerned with cannabis regulation

Instructor Profile:

Erik R. Janus is the president of M³ Technical & Regulatory Services LLC, a consulting firm offering technical and analytical services in a wide variety of areas that support the future of chemical risk assessment.

Mr. Janus is an environmental health science, risk assessment and regulatory toxicology expert with over 20 years of experience in a wide variety of sectors, including roles in academia, state and federal government agencies, corporations and trade associations and non-governmental organizations. Mr. Janus specializes in the science and regulation related to pesticides and endocrine-disrupting chemicals and has actively advocated for reduction of animal use in the testing of chemicals for many years. He currently holds leadership roles in the Society of Toxicology, Society of Risk Analysis and the International Society of Regulatory Toxicology & Pharmacology. Mr. Janus is an advisor to the PETA International Science Consortium and serves on the Board of Directors of the West Virginia chapter of the Hemp Industries Association, and is active here as an advocate and entrepreneur.

Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
21 CFR Part 11 Compliance for SaaS/Cloud Applications - 80202SEM

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed